Jens Juul Holst
Professor
Juul Holst Group
Blegdamsvej 3B, Panum, bygning 12-2-xx, 2200 København N.
2200 København N.
Jens Juul Holst is a professor at the Department of Biomedical Sciences and at the same time affiliated with the Novo Nordisk Foundation Center for Basic Metabolic Research. Jens Juul Holst's research concentrates on appetite regulation and hormones that regulate metabolism (digestion).
Jens is head of a research group that focuses on obesity and type 2 diabetes, especially with the aim of mapping hormonal disorders and the possibilities of treatment based on hormones. He has also taken part in developing a wide range of drugs used in treatment of type 2 diabetes.
Jens is co-founder of start-ups, including Antag Therapeutics and Bainan Biotech. BMI collaborate with Antag Therapeutics and Bainan Biotech on a variety of research projects with the aim of generating new knowledge that can be used in the prevention and treatment of diseases.
ID: 4207
Most downloads
-
3790
downloads
Meal induced gut hormone secretion is altered in aerobically trained compared to sedentary young healthy males
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
2709
downloads
Copenhagen study of overweight patients with coronary artery disease undergoing low energy diet or interval training: the randomized CUT-IT trial protocol
Research output: Contribution to journal › Journal article › Research › peer-review
Published -
528
downloads
Whole grain-rich diet reduces body weight and systemic low-grade inflammation without inducing major changes of the gut microbiome: a randomised cross-over trial
Research output: Contribution to journal › Journal article › Research › peer-review
Published